← Back to Clinical Trials
Recruiting NCT06367296

NCT06367296 Resistance Exercise Training in the Older Population With Obesity

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06367296
Status Recruiting
Phase —
Sponsor Universidad de La Frontera
Condition Aging
Study Type INTERVENTIONAL
Enrollment 32 participants
Start Date 2024-07-01
Primary Completion 2025-01-28

Eligibility & Interventions

Sex Female only
Min Age 60 Years
Max Age 79 Years
Study Type INTERVENTIONAL
All Conditions
Interventions
Prolonged resistance exercise training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 32 participants in total. It began in 2024-07-01 with a primary completion date of 2025-01-28.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Background: Aging leads to an alteration in the immune response, characterized by a chronic inflammatory state, and a progressive decrease in muscle quantity and quality, a situation that increases in women and in the presence of obesity. With respect to muscle quality, intramuscular infiltration of adipose tissue has been considered a relevant parameter, involved in the relationship between aging-obesity-inflammation. As a therapeutic strategy, physical training with resistance exercises (or also known as strength training) has been shown to be effective in increasing skeletal muscle mass in this age group. However, its role on muscle quality in normal-weight versus obese older women has not been fully addressed. Hypothesis: A 12-week resistance exercise training program is effective in improving muscle quality, immune response and physical performance in normal weight and obese older women. In addition to the above, the investigators hypothesize that women with obesity will present greater baseline alterations, so the percentage of change will be higher compared to older women with normal weight after the training program. Goals: The primary aim of this study is to evaluate the effects of a 12-week resistance exercise training on muscle quality (infiltration of intramuscular adipose tissue), immune response and physical performance in older women between 60 and 79 years of age with obesity compared to older women with normal weight of the same age range. Methodology: The present clinical trial will consider 2 groups of older women between 60 and 79 years old: normal weight (BMI=18.5 to 24.9 kg/m 2 and % fat \<25.9) and obese (BMI =30 to 39.9 Kg/m 2 and fat % \>32). Participants will perform 12 weeks of training with resistance exercises 3 times a week. Before and after training, intramuscular infiltration of adipose tissue (echogenicity) will be measured by ultrasound, followed by aspects of muscle architecture (muscle thickness, penile angle and fascicle length) and functional parameters of muscle quality (maximum strength determined by 1 repetition maximum-1RM, maximum voluntary isometric strength of knee extensors through a lower limb force and power transducer). Finally, fasting blood samples will be obtained (immune response) and physical performance, body composition, physical activity level, and quality of life will be evaluated.

Eligibility Criteria

Inclusion Criteria: * Older women between 60 and 79 years old who live in the community, that is, they do not live in nursing homes or similar. * Older people with normal weight (BMI=18.5 to 24.9 kg/m2 and % fat \<25.9) and those with obesity (BMI= 30 to 39.9 Kg/m2 and % fat \> 32). * Cognitive ability to follow verbal orders. Exclusion Criteria: * Neuromuscular or mobility disorders that do not allow resistance training to be carried out safely (debilitating arthritis, spasticity/rigidity, neurological disorders and paralysis). * Use of nutritional supplementation that can regulate skeletal muscle (leucine, glutamine, casein, whey-protein, fatty acids and creatine). * Untreated and/or uncontrolled chronic diseases. * Have carried out a training program with resistance exercises in the last 6 months.

Contact & Investigator

Central Contact

Nicolás Vidal-Seguel, MSc

✉ nicolasenrique.vidal@ufrontera.cl

📞 998595445

Principal Investigator

GABRIEL MARZUCA, Msc, PhD

STUDY DIRECTOR

Universidad de La Frontera. Temuco, Chile

Frequently Asked Questions

Who can join the NCT06367296 clinical trial?

This trial is open to female participants only, aged 60 Years or older, up to 79 Years, studying Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06367296 currently recruiting?

Yes, NCT06367296 is actively recruiting participants. Contact the research team at nicolasenrique.vidal@ufrontera.cl for enrollment information.

Where is the NCT06367296 trial being conducted?

This trial is being conducted at Temuco, Chile, Temuco, Chile.

Who is sponsoring the NCT06367296 clinical trial?

NCT06367296 is sponsored by Universidad de La Frontera. The principal investigator is GABRIEL MARZUCA, Msc, PhD at Universidad de La Frontera. Temuco, Chile. The trial plans to enroll 32 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology